BUSINESSQUARTZ
Senior source denied AstraZeneca and Bristol Myers Squibb were ever in merger talks
A senior source denied that AstraZeneca and Bristol Myers Squibb were ever in merger talks. A source close to the matter told Reuters there is 'no deal' and 'never was a deal to be done' between the two drugmakers.
Related Signal
Adjacent reporting
- AstraZeneca Is Said to Have Explored Bristol Myers Merger
- AstraZeneca shares drop 7% after report on $400 billion merger talks with Bristol Myers Squibb
- AstraZeneca holds talks with Bristol Myers Squibb over £300bn merger
- AstraZeneca stock sinks on reports of merger talks with Bristol Myers Squibb
- AstraZeneca Investors See Little Logic in Bristol Tie-Up
- AstraZeneca reported tie-up talks with Bristol-Myers Squibb are moving stocks. Analysts are puzzled.